[EN] SUBSTITUTED PYRAZOLOPYRIMIDINES AS IRAK4 INHIBITORS<br/>[FR] PYRAZOLOPYRIMIDINES SUBSTITUÉES EN TANT QU'INHIBITEURS D'IRAK4
申请人:BAYER AG
公开号:WO2021064077A1
公开(公告)日:2021-04-08
The present application relates to novel pyrazolopyrimidine derivatives for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments f or treatment and/or prophylaxis of diseases in humans and in animals, especially of proliferative disorder, autoimmune disorder, metabolic or inflammatory disorder characterized by an overreacting immune system, in particular rheumatological disorder, inflammatory skin disorder, cardiovascular disorder, lung disorder, kidney disorder, eye disorder, neurological disorder, pain disorder and cancer, in human as well as of allergic and/or inflammatory diseases in animals, especially of atopic dermatitis and/or Flea Allergy Dermatitis, and especially in domestic animals, particularly in dogs.